Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (Q3)Sep 30, 2025 | (Q2)Jun 30, 2025 | (Q1)Mar 31, 2025 | (FY)Dec 31, 2024 | (Q4)Dec 31, 2024 | (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow (Indirect Method) | ||||||||||
| Cash flow from continuing operating activities | 664.78%13.79B | -25.86%10.09B | 3.19%10.9B | -37.82%30.59B | -67.91%4.62B | -86.81%1.8B | 9.39%13.6B | 21.55%10.57B | 31.72%49.2B | 39.66%14.4B |
| Net income from continuing operations | 16.56%30.86B | -59.15%12.46B | -63.59%4.67B | -7.81%89.56B | -47.69%19.75B | 310.71%26.48B | -15.75%30.5B | -64.11%12.83B | 541.62%97.15B | 107.04%37.76B |
| Operating gains losses | 107.42%384M | -12.02%1.65B | -116.14%-340M | 38.68%-3.5B | -146.32%-2.31B | -620.33%-5.17B | 404.39%1.87B | 161.20%2.11B | -219.50%-5.71B | -129.41%-937M |
| Securities amortization | 21.38%-2.68B | -18.43%-3.04B | -63.99%-3.13B | -105.97%-11.35B | ---3.47B | ---3.41B | ---2.57B | ---1.91B | -386.75%-5.51B | ---- |
| Unrealized gains and losses of investment securities | -45.50%-22.32B | 68.86%-8.01B | 270.14%6.78B | 28.70%-49.3B | 88.17%-4.24B | -150.31%-15.34B | 20.70%-25.73B | 87.28%-3.98B | -209.54%-69.14B | -106.47%-35.88B |
| Other non cash items | -142.34%-719M | 14,468.18%6.32B | 257.49%1.5B | -73.88%-892M | -131.55%-1.59B | 169.88%1.7B | 97.60%-44M | 26.14%-955M | 83.31%-513M | 173.93%5.04B |
| Change in working capital | 187.02%4.93B | -141.09%-2.62B | -165.32%-1.84B | -133.19%-6.78B | -163.01%-6.8B | -31.00%-5.66B | -20.65%6.37B | -111.71%-695M | 234.09%20.44B | 285.91%10.79B |
| -Change in receivables | -181.73%-1.7B | 41.82%-939M | -802.56%-3.3B | 132.12%626M | 160.20%2.37B | 63.89%-602M | -493.38%-1.61B | 150.87%469M | 65.33%-1.95B | -52.23%912M |
| -Change in loss and loss adjustment expense reserves | -79.73%445M | 62.13%929M | 938.46%1.22B | -17.31%2.17B | -140.00%-712M | 283.07%2.2B | 126.48%573M | 431.82%117M | -35.22%2.63B | 460.32%1.78B |
| -Change in unearned premiums | 38.19%1.07B | -74.69%61M | -2.88%1.45B | -79.72%376M | -72.51%-2.13B | 29.38%775M | -70.10%241M | -11.39%1.49B | -0.38%1.85B | 30.15%-1.24B |
| -Change in other current assets | 11.74%-827M | -17.46%-565M | -394.06%-297M | -310.20%-206M | 62.66%1.11B | -751.82%-937M | -191.27%-481M | 110.08%101M | 101.90%98M | 43.79%683M |
| -Change in other current liabilities | -22.11%1.6B | -45.95%921M | 76.47%-1.29B | -189.03%-2.29B | -129.78%-559M | -39.87%2.05B | 2,466.67%1.7B | -107.10%-5.49B | 49.51%2.57B | 388.77%1.88B |
| -Change in other working capital | 147.40%4.34B | -150.85%-3.03B | -85.71%373M | -148.98%-7.47B | -201.49%-6.88B | -28.26%-9.15B | -12.37%5.95B | -70.34%2.61B | 225.92%15.24B | 103.70%6.78B |
| Cash from discontinued operating activities | ||||||||||
| Operating cash flow | 664.78%13.79B | -25.86%10.09B | 3.19%10.9B | -37.82%30.59B | -67.91%4.62B | -86.81%1.8B | 9.39%13.6B | 21.55%10.57B | 31.72%49.2B | 39.66%14.4B |
| Investing cash flow | ||||||||||
| Cash flow from continuing investing activities | -900.31%-39.05B | 762.70%49.36B | -412.05%-16.4B | 68.51%-10.29B | 158.06%4.27B | 86.08%-3.9B | -169.90%-7.45B | 59.55%-3.2B | 62.71%-32.66B | -20.67%-7.35B |
| Net PPE purchase and sale | -18.83%-5.59B | -7.12%-4.86B | 2.55%-4.28B | 2.23%-18.98B | 6.32%-5.35B | 11.35%-4.7B | 3.20%-4.54B | -18.31%-4.39B | -25.51%-19.41B | -25.26%-5.71B |
| Net business purchase and sale | ---- | ---- | ---- | 95.40%-396M | 15.00%-34M | 58.33%-20M | 98.31%-15M | 95.71%-327M | 18.78%-8.6B | 99.62%-40M |
| Net investment purchase and sale | -3,340.64%-33.41B | 1,982.26%54.02B | -833.45%-12.32B | 273.95%9.28B | 661.85%9.44B | 104.52%1.03B | -118.05%-2.87B | -48.16%1.68B | 91.36%-5.34B | -118.73%-1.68B |
| Net other investing changes | 76.50%-55M | 553.49%195M | 141.22%202M | -128.47%-195M | 642.86%572M | -346.32%-234M | -112.99%-43M | -369.23%-490M | 186.61%685M | 181.91%77M |
| Cash from discontinued investing activities | ||||||||||
| Investing cash flow | -900.31%-39.05B | 762.70%49.36B | -412.05%-16.4B | 68.51%-10.29B | 158.06%4.27B | 86.08%-3.9B | -169.90%-7.45B | 59.55%-3.2B | 62.71%-32.66B | -20.67%-7.35B |
| Financing cash flow | ||||||||||
| Cash flow from continuing financing activities | 127.24%835M | -236.53%-1.17B | 100.54%53M | 28.08%-10.36B | 1,315.44%1.65B | 33.89%-3.07B | 195.50%854M | 1.21%-9.8B | -766.73%-14.41B | 89.93%-136M |
| Net issuance payments of debt | 190.61%811M | -140.81%-555M | 104.28%196M | -67.43%-1.82B | 19.82%2.29B | -4,610.53%-895M | -35.61%1.36B | 10.13%-4.58B | -113.30%-1.09B | 6.52%1.91B |
| Net common stock issuance | --0 | --0 | --0 | 68.18%-2.92B | --0 | --0 | 74.57%-356M | 42.43%-2.56B | -16.77%-9.17B | 15.91%-2.19B |
| Net other financing charges | 101.11%24M | -307.33%-611M | 94.63%-143M | -35.57%-5.62B | -540.00%-638M | 37.80%-2.17B | 64.54%-150M | -601.05%-2.66B | -109.55%-4.15B | 126.95%145M |
| Cash from discontinued financing activities | ||||||||||
| Financing cash flow | 127.24%835M | -236.53%-1.17B | 100.54%53M | 28.08%-10.36B | 1,315.44%1.65B | 33.89%-3.07B | 195.50%854M | 1.21%-9.8B | -766.73%-14.41B | 89.93%-136M |
| Net cash flow | ||||||||||
| Beginning cash position | 135.03%101.23B | 18.51%42.86B | 25.19%48.38B | 6.17%38.64B | 20.21%37.99B | -14.97%43.07B | 32.46%36.16B | 6.17%38.64B | -58.97%36.4B | -5.25%31.6B |
| Current changes in cash | -372.86%-24.43B | 731.58%58.28B | -123.25%-5.45B | 367.34%9.95B | 52.50%10.54B | 72.83%-5.17B | -70.02%7.01B | 73.34%-2.44B | 104.10%2.13B | 141.04%6.91B |
| Effect of exchange rate changes | 257.47%311M | 198.97%96M | -72.73%-76M | -282.76%-212M | -225.40%-158M | 355.88%87M | -321.74%-97M | -193.62%-44M | 129.44%116M | -28.00%126M |
| End cash Position | 102.97%77.11B | 135.03%101.23B | 18.51%42.86B | 25.19%48.38B | 25.19%48.38B | 20.21%37.99B | -14.97%43.07B | 32.46%36.16B | 6.17%38.64B | 6.17%38.64B |
| Free cash flow | 383.06%8.2B | -42.35%5.23B | 7.27%6.62B | -61.00%11.62B | -108.35%-726M | -134.64%-2.9B | 17.01%9.07B | 23.96%6.17B | 36.10%29.79B | 51.06%8.69B |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | -- | -- | -- | Unqualified Opinion | -- | -- | -- | -- | Unqualified Opinion | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.